Arkolith/Insider Trading/INBX/Form 4

Kayyem Jon Faiz

DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Jun 7, 2024
Net Buying
Open-Market Buys
$997K
Open-Market Sells
$0
Net Open-Market Flow
$997K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2024Buy(P)8K$17.89$148K1.2M
Jun 5, 2024Buy(P)49K$17.23$849K1.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007919-24-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML